Insights

Innovative Therapeutic Platform CelSiege Biosciences is developing proprietary immunotherapies targeting circulating growth factors, offering a unique approach to treat difficult cancers like squamous NSCLC. This positions the company as a pioneer in actively overcoming therapy resistance, which could be of interest to partners seeking cutting-edge oncology solutions.

Growing Investment & Revenue With a funding of $25 million and current revenues between $1 million and $10 million, CelSiege shows substantial growth potential and investor interest, indicating a readiness to expand collaborations or suss out commercialization and licensing opportunities in the biotech sector.

Global Research Focus Headquartered in Marseille with operations in the United States, CelSiege targets the international market for innovative cancer treatments. This geographic positioning opens avenues for partnerships across multiple regions and access to diverse clinical and research collaborations.

Targeted Oncology Solutions CelSiege’s focus on active immunotherapies aimed at specific growth factors like EGF offers opportunities to connect with biotech and pharma companies interested in targeted cancer therapies, especially those seeking to address treatment resistance in lung cancer.

Technical & Digital Readiness The company's use of advanced digital tools and a professional website indicates a modern approach to research and communication, making it easier to engage with potential partners, investors, and healthcare providers in a rapidly evolving biotech landscape.

BAKX Therapeutics - We are hiring! Tech Stack

BAKX Therapeutics - We are hiring! uses 8 technology products and services including Cloudflare, Bunny Fonts, Font Awesome, and more. Explore BAKX Therapeutics - We are hiring!'s tech stack below.

Cloudflare

Content Management System

Bunny Fonts

Font Scripts

Font Awesome

Font Scripts

SiteGround

Platform As A Service

Yoast SEO

Search Engines

X-XSS-Protection

Security

WP-Optimize

Web Platform Extensions

Twitter

Widgets

BAKX Therapeutics - We are hiring! Email Formats	Example	Percentage
FLast@bakxtx.com	JDoe@bakxtx.com	100%

BAKX Therapeutics - We are hiring! Email Formats

Example

Percentage

FLast@bakxtx.com

JDoe@bakxtx.com

100%

Frequently Asked Questions

Where is BAKX Therapeutics - We are hiring!'s headquarters located?

BAKX Therapeutics - We are hiring!'s main headquarters is located at 565 Avenue du Prado Marseille, Provence-alpes-côte D'azur 13008 France. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is BAKX Therapeutics - We are hiring!'s official website and social media links?

BAKX Therapeutics - We are hiring!'s official website is celsiege.com and has social profiles on LinkedIn Crunchbase.

What is BAKX Therapeutics - We are hiring!'s SIC code NAICS code?

BAKX Therapeutics - We are hiring!'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does BAKX Therapeutics - We are hiring! have currently?

As of April 2026, BAKX Therapeutics - We are hiring! has approximately 4 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Co-Founder, President & Ceo: S. K.Director Of Finance And Operations: J. M.Senior Lab & Research Operations Manager: M. B.. Explore BAKX Therapeutics - We are hiring!'s employee directory with LeadIQ.

What industry does BAKX Therapeutics - We are hiring! belong to?

BAKX Therapeutics - We are hiring! operates in the Biotechnology Research industry.

What technology does BAKX Therapeutics - We are hiring! use?

BAKX Therapeutics - We are hiring!'s tech stack includes CloudflareBunny FontsFont AwesomeSiteGroundYoast SEOX-XSS-ProtectionWP-OptimizeTwitter.

What is BAKX Therapeutics - We are hiring!'s email format?

BAKX Therapeutics - We are hiring!'s email format typically follows the pattern of FLast@bakxtx.com. Find more BAKX Therapeutics - We are hiring! email formats with LeadIQ.

How much funding has BAKX Therapeutics - We are hiring! raised to date?

As of April 2026, BAKX Therapeutics - We are hiring! has raised $25M in funding. The last funding round occurred on Nov 18, 2021 for $25M.

When was BAKX Therapeutics - We are hiring! founded?

BAKX Therapeutics - We are hiring! was founded in 2025.

BAKX Therapeutics - We are hiring!

Q: What technology does BAKX Therapeutics - We are hiring! use?

BAKX Therapeutics - We are hiring!'s tech stack includes Bunny Fonts, Python, TensorFlow, PyTorch, Open Graph.

Q: What is BAKX Therapeutics - We are hiring!'s NAICS code?

BAKX Therapeutics - We are hiring!'s NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Biotechnology ResearchProvence-alpes-côte D'azur, France2-10 Employees

CelSiege Biosciences is pioneering multi-specific active immunotherapies to bring lasting control to squamous non-small cell lung cancer (sqNSCLC) and other difficult-to-treat cancers.

Built on a proprietary active immunotherapy platform, CelSiege develops first-in-class biologics that target circulating growth factors to overcome resistance to standard therapies. Our lead program, CS-01, selectively depletes epidermal growth factor (EGF) to open new possibilities in squamous NSCLC — a patient population with few treatment advances in decades.

Headquartered in Marseille, France, with operations in the United States, CelSiege unites a global team of scientists, clinicians, and partners dedicated to advancing a new generation of globally accessible therapeutics for patients in urgent need.

Insights

Similar companies to BAKX Therapeutics - We are hiring!

Bavarian Nordic

Alkermes

CytoDyn

Octapharma

Biogen

Medday Pharmaceuticals